PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
Public ClinicalTrials.gov record NCT00525954. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phospholipase Levels And Serological Markers of Atherosclerosis 2: An Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will be conducted at up to 25 U.S. centers and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 2 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.
Study identification
- NCT ID
- NCT00525954
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Not listed
- Completion
- Dec 2007 (Type not available)
- Last update posted
- Jan 7, 2008
2007
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mobile Heart Specialists | Mobile | Alabama | 36608 | — |
| Sonoran Health Specialists | Scottsdale | Arizona | 85260 | — |
| Pasco Cardiology Center | Hudson | Florida | 34667 | — |
| Charlotte Cardiovascular Institute | Port Charlotte | Florida | 33952 | — |
| Florida Cardiovascular Research Institute | Tampa | Florida | 33609 | — |
| Augusta Cardiology Clinic | Augusta | Georgia | 30901 | — |
| Louisville Cardiology Medical Group | Louisville | Kentucky | 40207 | — |
| Maine Research Associates | Auburn | Maine | 04210 | — |
| United Medical Associates | Binghamton | New York | 13901 | — |
| Cardiology PC | Syracuse | New York | 13210 | — |
| Austin Heart | Austin | Texas | 78705 | — |
| Clinical Research Associates of Tidewater | Norfolk | Virginia | 23507 | — |
| Wisconsin Heart, SC | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00525954, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2008 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00525954 live on ClinicalTrials.gov.